Targeted delivery of CD39 to the ischaemic brain improves outcomes in stroke

Project: Research

Status	Finished
Effective start/end date	1/01/18 → 31/12/21

Endothelial -targeted CD39 is protective in a mouse model of global forebrain ischaemia
Lee, N. T., Savvidou, I., Selan, C., Wright, D. K., Brkljaca, R., Chia, J. S. J., Calvello, I., Craenmehr, D. D. D., Larsson, P., Tarlac, V., Vuong, A., Carmichael, I., Wang, X., Peter, K., Robson, S. C., Nandurkar, H. H. & Sashindranath, M., Dec 2025, In: Journal of Neuroinflammation. 22, 1, 13 p., 115.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
Development of endothelial-targeted CD39 as a therapy for ischemic stroke
Lee, N. T., Savvidou, I., Selan, C., Calvello, I., Vuong, A., Wright, D. K., Brkljaca, R., Willcox, A., Chia, J. S. J., Wang, X., Peter, K., Robson, S. C., Medcalf, R. L., Nandurkar, H. H. & Sashindranath, M., Aug 2024, In: Journal of Thrombosis and Haemostasis. 22, 8, p. 2331-2344 14 p.
Research output: Contribution to journal › Article › Research › peer-review

1 Citation (Scopus)
CD39 in the development and progression of pulmonary arterial hypertension
Willcox, A. E. H., Lee, N. T., Nandurkar, H. H. & Sashindranath, M., Dec 2022, In: Purinergic Signalling. 18, 4, p. 409–419 11 p.
Research output: Contribution to journal › Review Article › Research › peer-review

Open Access

1 Citation (Scopus)

Project Details